Sun.Apr 07, 2024

article thumbnail

Watch: How Automated Trucking Will Impact Supply Chains

Supply Chain Brain

Improved use of tires and braking systems, not to mention safety, are among the gains expected when automated trucking is widely implemented in U.S. supply chains, says Peter Coratola Jr., CEO and founder of Ease Logistics.

article thumbnail

How to leave trucking better than you found it, with Jason Cowan

Overdrive Online

It was a central message of a veritable sermon small fleet owner Jason Cowan delivered to MATS attendees. In this Overdrive Radio podcast, the thought-provoking talk tracks from the owner's history and early mentors to long-term relationship value.

How To 77
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

United Air Calls Off May Investor Day After Safety Incidents

Supply Chain Brain

United already had planned several changes, including an additional day of in-person training for pilots starting in May, and a centralized curriculum for new maintenance technicians.

article thumbnail

5G Is Here — And With It, Greater Vulnerability to Cyberattack

Supply Chain Brain

With every advance in communications technology comes a fresh vulnerability that opens the user to cyberattack. So it goes with 5G mobile connectivity.

93
article thumbnail

Artificial Intelligence and the Transportation Industry

Artificial intelligence has quickly become a feature of everyday life: Using face ID to unlock a phone, communicating with online chatbots, and letting “smart” appliances help manage our homes are just a few of the ways that we interact with AI regularly. Forward-looking businesses are also using AI to transform their operations and gain a competitive edge.

article thumbnail

J&J to Buy Shockwave for $13B in Medical Device Play

Supply Chain Brain

J&J has been rapidly building its portfolio in both medical technology and drug development to help prepare for the impending loss of exclusivity for Stelara, its top-selling drug for psoriasis.

83